How 4D Molecular Therapeutics and Cohesity Transformed Contracting with Ironclad AI CLM

Ironclad Chief Customer Officer sits down with the Directors of Legal Operations at 4DMT and Cohesity to talk through innovative use cases for contract management with Ironclad's modern CLM platform. On this engaging panel, hear how biotech company 4D Molecular Therapeutics (4DMT) is conducting Phase 3 clinical trials for a gene therapy treatment targeting wet age-related macular degeneration (Wet AMD), a condition that can lead to blindness. In a highly competitive field with multiple drugs on the market, 4DMT's ability to quickly secure clinical trial sites and enroll patients represents a crucial competitive advantage. Leveraging Ironclad, 4DMT reduced cycle times from months to days, and gained a competitive advantage securing sites for its clinical trials. Perfect for: Legal operations professionals, procurement teams, general counsel, and contract managers looking to modernize their contract lifecycle management processes. #ContractManagement #CLM #LegalTech #LegalOps